TL1A, His-Tag, Avi-Tag, Biotin-Labeled Recombinant
Recombinant human TL1A (TNF-like ligand 1A (also known as Vascular endothelial growth inhibitor, VEGI or TNFSF15), encompassing amino acids 72 to 251(end). This construct contains an N-terminal His-tag (6xHis) followed by an Avi-Tag™. This protein was affinity purified. The protein runs as two bands in SDS-PAGE due to variable glycosylation, as confirmed by PNGase treatment.
≥90%
Aqueous buffer solution.
8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol
This protein is enzymatically biotinylated using Avi-Tag™ technology. Biotinylation is confirmed to be >90%.
For more information on enzymatic biotinylation, please see our Tech Note.
TNF-like ligand 1A (TL1A, also known as Vascular endothelial growth inhibitor, VEGI or TNFSF15) is an anti-angiogenic cytokine. It is an important mediator of inflammation, participates in innate and adaptive immune homeostasis through binding to its receptor, DR3, activating downstream signaling. Numerous studies showed that soluble TL1A can be detected in the serum of patients with T-cell mediated autoimmune diseases like rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease. In addition, recent clinical studies suggested that anti-TL1A antibody treatment is a promising therapeutic approach in inflammatory and auto-immune disorders.
Powered by Bioz
San Diego, CA 92121
858-202-1401
Products are for Research Use Only
COMPANY
Copyright © 2024
BPS Bioscience, Inc.
All rights reserved.
Diagrams on this website are created with BioRender.com.